Consolidation has created a widening gulf between small start-ups with innovative technology and large multi-faceted companies that control sales and distribution channels, making life difficult for mid-sized companies caught in the middle. Nowhere is this more true than in orthopedic devices. Now, some investors are finding opportunities in mid-sized companies by using them as platforms to build more substantial plays. The goal isn't market leadership, but value creation for shareholders, which can be done on a more modest scale.
by David Cassak
The medical device industry has always, to one degree or another, been characterized by big companies on the one hand and small start-ups on the other. Nor is this dichotomous...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.
